Odd hidden benefit in your brokerage account hands out cold hard cash

The Ultimate Hunting Ground For Takeover Deals: Here's How To Profit...

 ‌ ‌ ‌ 

The Ultimate Hunting Ground For Takeover Deals: Here's How To Profit... Odd hidden benefit in your brokerage account hands out cold hard cash The 'Oracle of Omaha' himself has used this very strategy to rake in as much as $4.5 billion in 'lost' cash in a single year. But this isn't some strategy that only the wall street elite can get in on with a million-dollar starting stake… now, you can do it too – if you know how to access the same 'back door' feature in your brokerage account.To see how it's done (and how much lost cash you could collect each week) click here. The Ultimate Hunting Ground For Takeover Deals: Here's How To Profit... By Nathan Slaughter   It's no secret that biopharma has long been (and will continue to be) fertile ground for mergers and acquisitions. As we speak, Amgen (Nasdaq: AMGN) is working to finalize the $27 billion takeover of Horizon Therapeutics. Pfizer (NYSE: PFE) didn't even finish digesting Biohaven Pharmaceuticals before it scooped up oncology specialist Seagen a few months ago for $43 billion. Not to be outdone, Merck (NYSE: MRK) just joined forces with Prometheus Biosciences in a splashy $11 billion deal that valued the latter at $200 per share, sending its stock soaring 75% on the news. This is by no means an all-inclusive list. These massive (11-figure) transactions have become almost commonplace among the legion of hungry biotech and pharmaceutical giants. Gilead, Novartis. Sanofi. Eli Lilly. Shoppers all. According to the Financial Times, dozens of major M&A deals were inked in the biopharma space last year, representing a total dollar volume of $127 billion. And that frenzied pace has actually picked up momentum since then. In fact, dealmaking activity in this sector is on pace to surpass $215 billion in 2023. Read More... Collect regular ai payouts of $1,034 or more   I've found a unique Texas company that's legally obligated to share 90% of the money it makes. It's raised its dividends 21 times in 19 years… to the tune of a 682% increase. But that's not all… it also grew its share price 685%. Now just imagine what will happen as more companies start using artificial intelligence and need what my "AI Enabler" provides. It could easily make the payout increases and gains I've just shared look like chump change. Here's how to get in on the action. You are receiving this email at its028@gmail.com as part of your subscription to StreetAuthority. To ensure that you receive these emails, please add us to your address book. Terms  |  Privacy  |  Unsubscribe ©2023  StreetAuthority 7600A Leesburg Pike, Suite 300 Falls Church, VA 22043 All rights reserved. Any reproduction, copying, or redistribution, in whole or in part, is prohibited.